UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Radiotherapy Increases the Permissiveness of Established Mammary Tumors to Rejection by Immunomodulatory Antibodies

Cancer research (Chicago, Ill.), 2012-07, Vol.72 (13), p.3163-3174

2012

Volltextzugriff (PDF)

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

The Journal of clinical investigation, 2013-03, Vol.123 (3), p.1371-1381

2013

Volltextzugriff (PDF)

CAR-T Plus Radiotherapy: A Promising Combination for Immunosuppressive Tumors

Frontiers in immunology, 2022-01, Vol.12, p.813832-813832

2022

Volltextzugriff (PDF)

DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors

The Journal of experimental medicine, 2008-12, Vol.205 (13), p.2965-2973

2008

Volltextzugriff (PDF)

Membrane-bound Fas ligand only is essential for Fas-induced apoptosis

Nature (London), 2009-10, Vol.461 (7264), p.659-663

2009

Volltextzugriff (PDF)

Estrogen-induced immune changes within the normal mammary gland

Scientific reports, 2022-11, Vol.12 (1), p.18986-18986, Article 18986

2022

Volltextzugriff (PDF)

Chemotherapy and radiotherapy: Cryptic anticancer vaccines

Seminars in immunology, 2010-06, Vol.22 (3), p.113-124

2010

Volltextzugriff (PDF)

Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodies

Proceedings of the National Academy of Sciences - PNAS, 2011-03, Vol.108 (10), p.4141-4146

2011

Volltextzugriff (PDF)

Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activity

Cell reports (Cambridge), 2024-10, Vol.43 (10), p.114834, Article 114834

2024

Volltextzugriff (PDF)

Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation

The Journal of clinical investigation, 2013-12, Vol.123 (12), p.5351-5360

2013

Volltextzugriff (PDF)

Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism

The Journal of experimental medicine, 2006-11, Vol.203 (12), p.2683-2690

2006

Volltextzugriff (PDF)

Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4 + Foxp3 - Cell-Mediated Modulation of CD103 + Dendritic Cells

Cancer immunology research, 2018-09, Vol.6 (9), p.1069-1081

2018

Volltextzugriff (PDF)

Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease

Proceedings of the National Academy of Sciences - PNAS, 2008-08, Vol.105 (31), p.10895-10900

2008

Volltextzugriff (PDF)

Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors

Journal for immunotherapy of cancer, 2018-06, Vol.6 (1), p.54-13, Article 54

2018

Volltextzugriff (PDF)

Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist

Proceedings of the National Academy of Sciences - PNAS, 2008-08, Vol.105 (32), p.11317-11322

2008

Volltextzugriff (PDF)

Molecular and genomic characterisation of a panel of human anal cancer cell lines

Cell death & disease, 2021-10, Vol.12 (11), p.959-15, Article 959

2021

Volltextzugriff (PDF)

The curative outcome of radioimmunotherapy in a mouse breast cancer model relies on mTOR signaling

Radiation research, 2014-08, Vol.182 (2), p.219

2014

Volltextzugriff (PDF)

The complexity of immune evasion mechanisms throughout the metastatic cascade

Nature immunology, 2024-10, Vol.25 (10), p.1793-1808

2024

Volltextzugriff (PDF)

Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells

Clinical cancer research, 2013-10, Vol.19 (20), p.5636-5646

2013

Volltextzugriff (PDF)

CD11c+ dendritic cells and B cells contribute to the tumoricidal activity of anti-DR5 antibody therapy in established tumors

The Journal of immunology (1950), 2010-07, Vol.185 (1), p.532-541

2010

Volltextzugriff (PDF)

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors

Nature medicine, 2009-10, Vol.15 (10), p.1170-1178

2009

Volltextzugriff (PDF)

CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory

Cancer discovery, 2021-10, Vol.11 (10), p.2582-2601

2021

Volltextzugriff (PDF)

Building immunity to cancer with radiation therapy

Cancer letters, 2015-11, Vol.368 (2), p.198-208

2015

Volltextzugriff (PDF)

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

The Journal of clinical investigation, 2016-01, Vol.126 (1), p.402-403

2016

Volltextzugriff (PDF)

Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune Defenses

International journal of radiation oncology, biology, physics, 2021-10, Vol.111 (2), p.502-514

2021

Volltextzugriff (PDF)

1 – 25 von 181

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(170)
Mit Volltextzugriff
(166)

Publikationsform

Sprache

Englisch
(181)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Radiotherapy Increases the Permissiveness of Established Mammary Tumors to Rejection by Immunomodulatory Antibodies

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

CAR-T Plus Radiotherapy: A Promising Combination for Immunosuppressive Tumors

DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors

Membrane-bound Fas ligand only is essential for Fas-induced apoptosis

Estrogen-induced immune changes within the normal mammary gland

Chemotherapy and radiotherapy: Cryptic anticancer vaccines

Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodies

Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activity

Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation

Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism

Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4 + Foxp3 - Cell-Mediated Modulation of CD103 + Dendritic Cells

Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease

Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors

Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist

Molecular and genomic characterisation of a panel of human anal cancer cell lines

The curative outcome of radioimmunotherapy in a mouse breast cancer model relies on mTOR signaling

The complexity of immune evasion mechanisms throughout the metastatic cascade

Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells

CD11c+ dendritic cells and B cells contribute to the tumoricidal activity of anti-DR5 antibody therapy in established tumors

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors

CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory

Building immunity to cancer with radiation therapy

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune Defenses

Suchergebnisse filtern